The results showed that berberine and coptisine significantly lowered the KRAS mRNA levels in the two cancer cell lines, while not in the normal BEAS-2B cells (Fig. 7b and Supplementary Figs. 38 and 39). The gene discussed is KRAS; the disease is cancer.